Production of human monoclonal antibodies in vitro

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/302122

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Antibodies are defence molecules that permeate our tissues. The diversity of antibodies in a healthy organism is vast, providing the potential to neutralise almost any biological molecule or pathogen with exquisite selectivity. We have invented a cell culture-based platform to generate and select human antibodies specific for any desired target. Unlike most antibodies currently used in laboratories, these antibodies will be usable as drugs as well as for detection of disease.

Funded Activity Details

Start Date: 01-01-2004

End Date: 01-01-2007

Funding Scheme: Early Career Fellowships

Funding Amount: $358,500.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical microbiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

B lymphocyte | biotechnology | cell culture | monoclonal antibody | recombinant engineering

Related Links